38
Participants
Start Date
October 1, 2022
Primary Completion Date
July 1, 2024
Study Completion Date
July 1, 2024
Personalized OSA messages
Participants will receive personalized OSA messages designed to nudge and navigate them toward evaluation and treatment for OSA. Participants will complete questionnaires at baseline and at study follow-up.
Control
Participants will complete questionnaires at baseline and at study follow-up. At the end of the study period, participants will receive the OSA message intervention.
Brigham and Women's Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Brigham and Women's Hospital
OTHER